These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36911005)

  • 1. A Comprehensive Review on Various Aspects of SARS-CoV-2 (COVID-19) Vaccines.
    Pordanjani SR; Pordanjani AR; Askarpour H; Arjmand M; Babakhanian M; Amiri M; Mazaheri E
    Int J Prev Med; 2022; 13():151. PubMed ID: 36911005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.
    Shiravi AA; Ardekani A; Sheikhbahaei E; Heshmat-Ghahdarijani K
    Cardiol Ther; 2022 Mar; 11(1):13-21. PubMed ID: 34845662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
    Gasmi A; Srinath S; Dadar M; Pivina L; Menzel A; Benahmed AG; Chirumbolo S; Bjørklund G
    Clin Immunol; 2022 Apr; 237():108958. PubMed ID: 35218966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination is the most effective and best way to avoid the disease of COVID-19.
    Lotfi H; Mazar MG; Ei NMH; Fahim M; Yazdi NS
    Immun Inflamm Dis; 2023 Aug; 11(8):e946. PubMed ID: 37647441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.
    Esmaeilzadeh A; Maleki AJ; Moradi A; Siahmansouri A; Yavari MJ; Karami P; Elahi R
    Expert Rev Vaccines; 2022 Oct; 21(10):1377-1394. PubMed ID: 35986451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Adverse Effects of COVID-19 Vaccines on Iranian Healthcare Workers: Comparison of Four Available Vaccines in Tehran: A Retrospective Cross-sectional Study.
    Abdollahi A; Naseh I; Kalroozi F; Kazemi-Galougahi MH; Nezamzadeh M; Qorbanzadeh A; Ameri R; Taghavi H; Zoshk MY
    Oman Med J; 2023 Mar; 38(2):e486. PubMed ID: 37168286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
    Majed SO
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
    Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers in Shoushtar, Iran.
    Nabizadeh E; Honarmandpour F; Mashhadizade R; Honarmandpour A
    Clin Pathol; 2023; 16():2632010X231166798. PubMed ID: 37155553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccines: Current Status and Implication for Use in Indonesia.
    Ophinni Y; Hasibuan AS; Widhani A; Maria S; Koesnoe S; Yunihastuti E; Karjadi TH; Rengganis I; Djauzi S
    Acta Med Indones; 2020 Oct; 52(4):388-412. PubMed ID: 33377885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
    Sughayer MA; Souan L; Abu Alhowr MM; Al Rimawi D; Siag M; Albadr S; Owdeh M; Al Atrash T
    Vaccine; 2022 May; 40(20):2841-2847. PubMed ID: 35397946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines.
    Doroftei B; Ciobica A; Ilie OD; Maftei R; Ilea C
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33804914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.